Cargando…

De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary

The population with intellectual disabilities is one of the most vulnerable groups in society. Medication use is the main therapeutic intervention in this population and psychotropic medications can be prescribed for mental health conditions and for challenging behaviors. Clinical experience of pres...

Descripción completa

Detalles Bibliográficos
Autor principal:	Flood, Bernadette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025292/ https://www.ncbi.nlm.nih.gov/pubmed/29601493 http://dx.doi.org/10.3390/pharmacy6020028

Ejemplares similares

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

Psychotropic prescribing practices in adults with intellectual disability and autism spectrum disorder in Richmond Neurodevelpmental Services
por: Dissanayake, Anushka, et al.
Publicado: (2021)

Management of psychotropic medications in adults with intellectual disability: a scoping review
por: Costello, Ashley, et al.
Publicado: (2022)

Management of psychotropic medications in adults with intellectual disability: a scoping review protocol
por: Costello, Ashley, et al.
Publicado: (2022)

Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
por: Henderson, Angela, et al.
Publicado: (2020)

Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
por: Sheehan, Rory, et al.
Publicado: (2015)

COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021)

A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study
por: Sheehan, Rory, et al.
Publicado: (2019)

Experiences of the Medication Use Process by People with Intellectual Disabilities. What a Pharmacist Should Know!
por: Flood, Bernadette, et al.
Publicado: (2021)

Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia
por: Song, Menghuan, et al.
Publicado: (2020)

Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK
por: Sheehan, Rory, et al.
Publicado: (2019)

Commentary: The origins of intellectual disability
por: Plomin, Robert
Publicado: (2022)

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
por: García‐Domínguez, Laura, et al.
Publicado: (2022)

National Prescribing Patterns of Psychotropic Medications in Older Adults in Oman
por: Al-Shehhi, Afaf, et al.
Publicado: (2023)

Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour
por: Laermans, P., et al.
Publicado: (2023)

Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany
por: Koch, Andrea, et al.
Publicado: (2018)

A Snapshot of Prescribing in Intellectual Disability CAMHS
por: Simpson, Struan
Publicado: (2022)

‘Prescribing’ psychotropic medication to our rivers and estuaries
por: Ford, Alex T., et al.
Publicado: (2019)

Safety of People with Intellectual Disabilities in Hospital. What Can the Hospital Pharmacist Do to Improve Quality of Care?
por: Flood, Bernadette
Publicado: (2017)

Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review
por: Adams, Danielle, et al.
Publicado: (2023)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

Psychotropic medication prescribing during the COVID-19 pandemic
por: Hirschtritt, Matthew E., et al.
Publicado: (2021)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Audit of Adherence to Prescribing Guidelines of Psychotropic Drugs for People With Intellectual Disability and Behaviours That Challenge -Specialist Support Team -SST-Merseycare NHS Foundation Trust
por: Hasan, Syeda, et al.
Publicado: (2022)

The impact of prescribed psychotropics on youth
por: Lakhan, Shaheen E, et al.
Publicado: (2007)

Rational prescribing of psychotropic medicines
por: Ghodse, Hamid
Publicado: (2004)

COVID-19-related prescribing challenge in intellectual disability
por: Rauf, Bushra, et al.
Publicado: (2021)

Observed Dietary Intake in Adults with Intellectual Disability Living in Group Homes
por: Hamzaid, Nur Hana, et al.
Publicado: (2019)

Prescribing antipsychotic medication for adults with intellectual disability: shared responsibilities between mental health services and primary care
por: Paton, Carol, et al.
Publicado: (2022)

The Use of Psychotropic Medication in Iranian Children with Developmental Disabilities
por: McConkey, Roy, et al.
Publicado: (2021)

Weight Gain, Obesity, and Psychotropic Prescribing
por: Nihalani, Nikhil, et al.
Publicado: (2011)

Prescribing opioids and psychotropic drugs in pregnancy
por: Patrick, Stephen W, et al.
Publicado: (2017)

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Psychotropic Medication Prescribing to Patients with Dementia Admitted to Acute Hospitals in Ireland
por: Timmons, Suzanne, et al.
Publicado: (2023)

An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour
por: bij de Weg, Janouk C., et al.
Publicado: (2021)

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic
por: Luykx, Jurjen J., et al.
Publicado: (2020)

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
por: Zito, Julie M., et al.
Publicado: (2021)

National trends in psychotropic medication prescribing before and during the COVID-19 pandemic()
por: Sanborn, Molly, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tac79l1de09ser7pjrjbik4u45